EVER Pharma
Erwin Loerracher has a diverse work experience spanning various industries. Erwin is currently serving as the Chief Information Officer at EVER Neuro Pharma since March 2020. Prior to this, they worked at Lenzing Group as the Team Lead Global IT - PEOPLE Systems from January 2017 to March 2020, focusing on business partnering, strategy execution, and Lean/SixSigma BlackBelt. From November 2015 to December 2016, they held the position of Head IT Sandoz Unterach at Novartis, and from May 2012 to October 2015, they served as the IT Governance, Quality and Project Portfolio Manager at the same company. Erwin also has experience working at Baxter International Inc. as a Project Manager / Project Management Office from 2008 to April 2012. In 2006, they worked as a Trainer for Benesse Corporation and Berlitz, Japan, during a 1 ½ year stay abroad in Japan. Erwin also has self-employment experience as an Owner from 2003 to 2007, and earlier in their career, they held the position of Head of Internet & Programming at Bazar Zeitungsverlag from 1999 to 2003.
Erwin Loerracher earned a Mag. (FH) degree in Information Technology Project Management from Fachhochschule des BFI Wien, where they studied from 2002 to 2006. In 2005 to 2006, they also attended Ritsumeikan Asia Pacific University, but no degree or field of study information is provided for this period.
EVER Pharma
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics. From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety. Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.